Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 12/2018

01-11-2018 | Editorial Commentary

Quantification of myocardial blood flow with dynamic SPECT acquisitions: ready for prime time?

Authors: Fabien Hyafil, François Rouzet, Dominique Le Guludec

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2018

Login to get access

Excerpt

Thanks to PET studies, the measurement of global and regional stress and rest blood flow and flow reserve has proven to be of diagnostic and prognostic value in various clinical settings. A growing number of nuclear medicine sites in Europe are now using cardiac-centred gamma cameras for myocardial perfusion imaging (MPI). In so-called “CZT cameras” a cadmium-zinc-telluride (CZT) crystal is used in place of the conventional sodium/ iodine (Na/I) crystal for the detection of gamma rays. Manufacturers have taken advantage of these much thinner and more flexible CZT detectors to design gamma cameras dedicated to cardiac imaging that offer a larger surface for signal detection and focused on the heart region [1]. …
Literature
1.
Agostini D, Marie PY, Ben-Haim S, Rouzet F, Songy B, Giordano A, et al. Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging. 2016;43:2423–32.CrossRefPubMed
2.
Imbert L, Poussier S, Franken PR, Songy B, Verger A, Morel O, et al. Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: a comprehensive analysis of phantom and human images. J Nucl Med. 2012;53:1897–903.CrossRefPubMed
3.
Verger A, Imbert L, Yagdigul Y, Fay R, Djaballah W, Rouzet F, et al. Factors affecting the myocardial activity acquired during exercise SPECT with a high-sensitivity cardiac CZT camera as compared with conventional Anger camera. Eur J Nucl Med Mol Imaging. 2014;41:522–8.CrossRefPubMed
4.
Ben-Haim S, Murthy VL, Breault C, Allie R, Sitek A, Roth N, et al. Quantification of myocardial perfusion reserve using dynamic SPECT imaging in humans: a feasibility study. J Nucl Med. 2013;54:873–9.CrossRefPubMed
5.
Agostini D, Roule V, Nganoa C, Roth N, Baavour R, Parienti JJ, et al. First validation of myocardial flow reserve assessed by dynamic (99m)Tc-sestamibi CZT-SPECT camera: head to head comparison with (15)O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging. 2018;45:1079–90.CrossRefPubMedCentralPubMed
6.
Nkoulou R, Fuchs TA, Pazhenkottil AP, Kuest SM, Ghadri JR, Stehli J, et al. Absolute myocardial blood flow and flow reserve assessed by gated SPECT with cadmium-zinc-telluride detectors using 99mTc-tetrofosmin: head-to-head comparison with 13N-ammonia PET. J Nucl Med. 2016;57:1887–92.CrossRefPubMed
7.
8.
Klein R, Renaud JM, Ziadi MC, Thorn SL, Adler A, Beanlands RS, et al. Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 PET and a highly automated analysis program. J Nucl Cardiol. 2010;17:600–16.CrossRefPubMed
9.
El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med. 2009;50:1062–71.CrossRefPubMed
10.
Kitkungvan D, Johnson NP, Roby AE, Patel MB, Kirkeeide R, Gould KL. Routine clinical quantitative rest stress myocardial perfusion for managing coronary artery disease: clinical relevance of test-retest variability. JACC Cardiovasc Imaging. 2017;10:565–77.CrossRefPubMed
11.
Farhad H, Dunet V, Bachelard K, Allenbach G, Kaufmann PA, Prior JO. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging. Eur Heart J Cardiovasc Imaging. 2013;14:1203–10.CrossRefPubMed
12.
Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740–8.CrossRefPubMed
13.
Juneau D, deKemp RA, Beanlands RSB. Reporting myocardial flow reserve with PET. Ready or not, here it is! But walk before you fly! J Nucl Cardiol. 2018;25:164–8.CrossRefPubMed
14.
Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R, et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013;62:1639–53.CrossRefPubMed
Metadata
Title
Quantification of myocardial blood flow with dynamic SPECT acquisitions: ready for prime time?
Authors
Fabien Hyafil
François Rouzet
Dominique Le Guludec
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-4127-8

Other articles of this Issue 12/2018

European Journal of Nuclear Medicine and Molecular Imaging 12/2018 Go to the issue

Original Article

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)

Original Article

[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery

Original Article

FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients

Review Article

18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis

Editorial Commentary

Prostate cancer imaging: when the game gets tough, the hard one gets done!

Original Article

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer